CY2107B1 - Risperidone pamoate - Google Patents

Risperidone pamoate

Info

Publication number
CY2107B1
CY2107B1 CY9800009A CY9800009A CY2107B1 CY 2107 B1 CY2107 B1 CY 2107B1 CY 9800009 A CY9800009 A CY 9800009A CY 9800009 A CY9800009 A CY 9800009A CY 2107 B1 CY2107 B1 CY 2107B1
Authority
CY
Cyprus
Prior art keywords
pct
risperidone
sec
compositions
compound
Prior art date
Application number
CY9800009A
Other languages
English (en)
Inventor
Jean Louis Mesens
Jozef Peeters
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CY2107B1 publication Critical patent/CY2107B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/105—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
    • C07C65/11—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
CY9800009A 1993-04-28 1998-06-16 Risperidone pamoate CY2107B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93201216 1993-04-28

Publications (1)

Publication Number Publication Date
CY2107B1 true CY2107B1 (en) 2002-04-26

Family

ID=8213799

Family Applications (1)

Application Number Title Priority Date Filing Date
CY9800009A CY2107B1 (en) 1993-04-28 1998-06-16 Risperidone pamoate

Country Status (32)

Country Link
US (2) US5612346A (lv)
EP (1) EP0697019B1 (lv)
JP (1) JP3478397B2 (lv)
KR (1) KR100307101B1 (lv)
CN (1) CN1041727C (lv)
AT (1) ATE163418T1 (lv)
AU (1) AU675136B2 (lv)
BG (1) BG62004B1 (lv)
CA (1) CA2160366C (lv)
CY (1) CY2107B1 (lv)
CZ (1) CZ286688B6 (lv)
DE (1) DE69408666T2 (lv)
DK (1) DK0697019T3 (lv)
ES (1) ES2113652T3 (lv)
FI (1) FI109125B (lv)
GR (1) GR3026028T3 (lv)
HK (1) HK1006059A1 (lv)
HU (1) HU218212B (lv)
IL (1) IL109448A (lv)
LV (1) LV12315B (lv)
NO (1) NO305083B1 (lv)
NZ (1) NZ266143A (lv)
PH (1) PH30476A (lv)
PL (1) PL182466B1 (lv)
RO (1) RO115955B1 (lv)
RU (1) RU2131428C1 (lv)
SG (1) SG47046A1 (lv)
SI (1) SI9420031B (lv)
SK (1) SK280589B6 (lv)
TW (1) TW376319B (lv)
WO (1) WO1994025460A1 (lv)
ZA (1) ZA942909B (lv)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1074923C (zh) * 1993-11-19 2001-11-21 詹森药业有限公司 微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
US5453425A (en) * 1994-07-11 1995-09-26 Janssen Pharmaceutica N.V. Risperidone oral formulation
TW487572B (en) * 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
US6617321B2 (en) 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
CZ300725B6 (cs) * 1997-09-30 2009-07-29 Eli Lilly And Company 2-Methylthienbenzodiazepinová formulace
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
EA002580B1 (ru) * 1998-09-30 2002-06-27 Эли Лилли Энд Компани Готовая препаративная форма 2-метил-тиено-бензодиазепина
JP2002529468A (ja) * 1998-11-12 2002-09-10 メルク エンド カムパニー インコーポレーテッド ＧＡＢＡ−Ａα−５逆活性薬の治療性多形およびそのパモエート組成物
FR2802101B1 (fr) 1999-12-10 2003-02-28 Aventis Pharma Sa Association de cymemazine et d'un neuroleptique atypique
US6770478B2 (en) * 2000-02-10 2004-08-03 The Regents Of The University Of California Erythrocytic cells and method for preserving cells
US6495164B1 (en) 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
WO2002043766A1 (fr) * 2000-11-29 2002-06-06 Takeda Chemical Industries, Ltd. Compositions medicinales et leur procede de preparation
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
AU2003250472A1 (en) * 2002-08-23 2004-03-11 Ranbaxy Laboratories Limited Stable aqueous solutions of risperidone and methods for their preparation
KR20040034996A (ko) * 2002-10-18 2004-04-29 한미약품 주식회사 리스페리돈의 개선된 제조방법
WO2004094415A1 (en) * 2003-04-22 2004-11-04 Synthon B.V. Risperidone monohydrochloride
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
ES2315721T5 (es) * 2003-10-23 2012-08-24 Otsuka Pharmaceutical Co., Ltd. Formulación de aripiprazol inyectable estéril de liberación controlada y procedimiento
CA2547639A1 (en) * 2003-12-02 2005-06-16 B&B Beheer Nv Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
US7884096B2 (en) * 2003-12-02 2011-02-08 Pharmaneuroboost N.V. Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
CA2554959A1 (en) * 2004-01-29 2005-08-11 Neuromolecular, Inc. Combination of a nmda receptor antagonist and a mao-inhibitor or a gadpf-inhibitor for the treatment of central nervous system-related conditions
ATE511512T1 (de) * 2005-01-05 2011-06-15 Lilly Co Eli Olanzapinpamoat-dihydrat
EP1695973A1 (en) * 2005-02-24 2006-08-30 Neuro3D Ocaperidone salt and pharmaceutical compositions containing the same
AR055099A1 (es) * 2005-07-28 2007-08-08 Alza Corp Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
EP1933814A2 (en) * 2005-09-15 2008-06-25 Elan Pharma International Limited Nanoparticulate aripiprazole formulations
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
CA2687979C (en) 2007-05-25 2017-07-04 Tolmar Therapeutics, Inc. Sustained delivery formulations of risperidone compounds
UA97286C2 (ru) * 2007-07-31 2012-01-25 Оцука Фармасьютикал Ко., Лтд. Способ изготовления суспензии арипипразола и лиофилизированного состава
ES2868353T3 (es) * 2007-12-19 2021-10-21 Janssen Pharmaceutica Nv Régimen de dosificación asociado a ésteres de paliperidona inyectables de larga acción
RU2627469C2 (ru) 2011-03-18 2017-08-08 Алкермес Фарма Айэленд Лимитед Фармацевтические композиции, содержащие водонерастворимое антипсихотическое средство и сложные эфиры сорбита
US9040695B2 (en) * 2011-04-26 2015-05-26 Torrent Pharmaceuticals Limited Acid addition salts of risperidone and pharmaceutical compositions thereof
WO2013142198A1 (en) 2012-03-19 2013-09-26 Alkermes Pharma Ireland Limited Pharmaaceutical compositions comprising fatty acid esters
JP6219918B2 (ja) 2012-03-19 2017-10-25 アルカームス ファーマ アイルランド リミテッド グリセロールエステルを含む医薬組成物
CA2867137C (en) * 2012-03-19 2020-12-08 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising aripiprazole prodrugs and benzyl alcohol
AU2013245011B2 (en) 2012-04-04 2017-11-23 Intervet International B.V. Solid oral pharmaceutical compositions for isoxazoline compounds
CN102659577B (zh) * 2012-04-07 2014-07-02 安徽绩溪县徽煌化工有限公司 一种亚甲基双羟基萘酸的制备方法
JP6654042B2 (ja) 2012-09-19 2020-02-26 アルカームス ファーマ アイルランド リミテッド 貯蔵安定性が改善された医薬組成物
NZ706067A (en) * 2012-09-26 2016-07-29 Tangent Reprofiling Ltd Modulators of androgen synthesis
US9375433B2 (en) 2012-09-26 2016-06-28 Tangent Reprofiling Limited Modulators of androgen synthesis
CA2943213C (en) 2014-03-20 2022-07-05 Alkermes Pharma Ireland Limited Aripiprazole formulations having increased injection speeds
CN106831594B (zh) * 2017-01-18 2018-02-02 力赛生物医药科技（厦门）有限公司 可乐定双羟萘酸盐及其制备方法
CA3092335A1 (en) 2018-03-05 2019-09-12 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles

Also Published As

Publication number Publication date
FI955166A (fi) 1995-10-27
SG47046A1 (en) 1998-03-20
TW376319B (en) 1999-12-11
HU9501934D0 (en) 1995-09-28
CZ270695A3 (en) 1996-01-17
NO954275L (no) 1995-10-26
ZA942909B (en) 1995-10-26
BG100094A (bg) 1996-05-31
CN1121719A (zh) 1996-05-01
EP0697019B1 (en) 1998-02-25
BG62004B1 (bg) 1998-12-30
IL109448A (en) 1997-03-18
ES2113652T3 (es) 1998-05-01
HU218212B (hu) 2000-06-28
CN1041727C (zh) 1999-01-20
SI9420031B (sl) 2002-08-31
IL109448A0 (en) 1994-07-31
FI955166A0 (fi) 1995-10-27
PH30476A (en) 1997-05-28
KR100307101B1 (ko) 2001-11-30
DE69408666D1 (de) 1998-04-02
US5723467A (en) 1998-03-03
FI109125B (fi) 2002-05-31
JP3478397B2 (ja) 2003-12-15
PL182466B1 (pl) 2002-01-31
SK280589B6 (sk) 2000-04-10
RU2131428C1 (ru) 1999-06-10
LV12315B (lv) 2000-03-20
EP0697019A1 (en) 1996-02-21
LV12315A (lv) 1999-07-20
DK0697019T3 (da) 1998-09-28
NO305083B1 (no) 1999-03-29
HK1006059A1 (en) 1999-02-05
CA2160366C (en) 2006-06-06
WO1994025460A1 (en) 1994-11-10
PL311282A1 (en) 1996-02-05
CA2160366A1 (en) 1994-11-10
RO115955B1 (ro) 2000-08-30
NZ266143A (en) 1996-07-26
ATE163418T1 (de) 1998-03-15
NO954275D0 (no) 1995-10-26
US5612346A (en) 1997-03-18
AU6721694A (en) 1994-11-21
GR3026028T3 (en) 1998-04-30
AU675136B2 (en) 1997-01-23
CZ286688B6 (en) 2000-06-14
DE69408666T2 (de) 1998-06-18
SK131395A3 (en) 1996-06-05
SI9420031A (en) 1996-08-31
HUT72970A (en) 1996-06-28
JPH08509482A (ja) 1996-10-08

Similar Documents

Publication Publication Date Title
CY2107B1 (en) Risperidone pamoate
FR05C0045I2 (lv)
GR3022510T3 (en) Lyospheres comprising gonadotropin
HU9501719D0 (en) Polypeptide and anti-hiv agent prepared therefrom
PL310171A1 (en) Novel imidazopyridines
TW263499B (lv)
ES2104386T3 (es) Compuesto intermedio para la acitromicina.
GB9126725D0 (en) Process
TW248530B (lv)
TW261516B (lv)
ZA939227B (en) Novel triazoloquinazolines,their preparation and use
AU1466592A (en) Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
HUT72329A (en) Application of riluzole as a radiorestorer